A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions

HeartburnUpper Abdominal PainNauseaAcid Regurgitation

Interventions

DRUG

Esomeprazole

40mg Oral

DRUG

Lansoprazole

30mg Oral

DRUG

Pantoprazole

40mg Oral